Journal
CANCER SCIENCE
Volume 110, Issue 10, Pages 3215-3224Publisher
WILEY
DOI: 10.1111/cas.14171
Keywords
EGFR mutation; EGFR-TKI; non-small cell lung cancer; patient-derived xenograft; SHO mouse
Categories
Funding
- Japan Society for the Promotion of Science [16H05308, 18K08141]
- Japan Agency for Medical Research and Development [16cm0106513h0001]
- Kanazawa University Extramural Collaborative Research Grant of Cancer Research Institute
- Grants-in-Aid for Scientific Research [18K08141, 16H05308] Funding Source: KAKEN
Ask authors/readers for more resources
Patient-derived xenograft (PDX) models are a useful tool in cancer biology research. However, the number of lung cancer PDX is limited. In the present study, we successfully established 10 PDX, including three adenocarcinoma (AD), six squamous cell carcinoma (SQ) and one large cell carcinoma (LA), from 30 patients with non-small cell lung cancer (NSCLC) (18 AD, 10 SQ, and 2 LA), mainly in SCID hairless outbred (SHO) mice (Crlj:SHO-Prkdc(scid)Hr(hr)). Histology of SQ, advanced clinical stage (III-IV), status of lymph node metastasis (N2-3), and maximum standardized uptake value >= 10 when evaluated using a delayed F-18-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) scan was associated with successful PDX establishment. Histological analyses showed that PDX had histology similar to that of patients' surgically resected tumors (SRT), whereas components of the microenvironment were replaced with murine cells after several passages. Next-generation sequencing analyses showed that after two to six passages, PDX preserved the majority of the somatic mutations and mRNA expressions of the corresponding SRT. Two out of three PDX with AD histology had epidermal growth factor receptor (EGFR) mutations (L858R or exon 19 deletion) and were sensitive to EGFR tyrosine kinase inhibitors (EGFR-TKI), such as gefitinib and osimertinib. Furthermore, in one of the two PDX with an EGFR mutation, osimertinib resistance was induced that was associated with epithelial-to-mesenchymal transition. This study presented 10 serially transplantable PDX of NSCLC in SHO mice and showed the use of PDX with an EGFR mutation for analyses of EGFR-TKI resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available